1. Home
  2. PSTX vs ASA Comparison

PSTX vs ASA Comparison

Compare PSTX & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • ASA
  • Stock Information
  • Founded
  • PSTX 2014
  • ASA 1958
  • Country
  • PSTX United States
  • ASA United States
  • Employees
  • PSTX N/A
  • ASA N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • ASA Precious Metals
  • Sector
  • PSTX Health Care
  • ASA Industrials
  • Exchange
  • PSTX Nasdaq
  • ASA Nasdaq
  • Market Cap
  • PSTX 360.4M
  • ASA 381.5M
  • IPO Year
  • PSTX 2020
  • ASA N/A
  • Fundamental
  • Price
  • PSTX $2.71
  • ASA $20.02
  • Analyst Decision
  • PSTX Strong Buy
  • ASA
  • Analyst Count
  • PSTX 2
  • ASA 0
  • Target Price
  • PSTX $15.00
  • ASA N/A
  • AVG Volume (30 Days)
  • PSTX 557.2K
  • ASA 58.4K
  • Earning Date
  • PSTX 11-07-2024
  • ASA 12-03-2024
  • Dividend Yield
  • PSTX N/A
  • ASA 0.20%
  • EPS Growth
  • PSTX N/A
  • ASA 302.95
  • EPS
  • PSTX N/A
  • ASA 4.56
  • Revenue
  • PSTX $150,858,000.00
  • ASA $1,993,559.00
  • Revenue This Year
  • PSTX $64.38
  • ASA N/A
  • Revenue Next Year
  • PSTX N/A
  • ASA N/A
  • P/E Ratio
  • PSTX N/A
  • ASA $4.38
  • Revenue Growth
  • PSTX 203.18
  • ASA N/A
  • 52 Week Low
  • PSTX $1.87
  • ASA $13.18
  • 52 Week High
  • PSTX $4.27
  • ASA $22.78
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 46.81
  • ASA 38.85
  • Support Level
  • PSTX $2.63
  • ASA $19.43
  • Resistance Level
  • PSTX $2.82
  • ASA $20.71
  • Average True Range (ATR)
  • PSTX 0.33
  • ASA 0.41
  • MACD
  • PSTX -0.03
  • ASA -0.16
  • Stochastic Oscillator
  • PSTX 19.86
  • ASA 21.91

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation primarily through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: